Controlling Microbial Growth in the Body: Antimicrobial Drugs and Resistance

Controlling Microbial Growth in the Body

Introduction

This study guide summarizes key concepts from Chapter 10 on antimicrobial drugs and resistance, focusing on mechanisms of action, efficacy testing, and the development of resistance. Understanding these principles is essential for microbiology students preparing for exams and clinical applications.

Mechanisms of Action of Antimicrobial Drugs

Inhibition of Cell Wall Synthesis

Many antibiotics target the synthesis of peptidoglycan, a critical component of bacterial cell walls. Disruption of this process weakens the cell wall, leading to cell lysis due to osmotic pressure.

• Peptidoglycan Structure: Composed of alternating N-acetylglucosamine (NAG) and N-acetylmuramic acid (NAM) subunits cross-linked by peptide bridges.

• Mechanism: Drugs such as penicillins and cephalosporins interfere with enzymes (transpeptidases) that cross-link NAM subunits, leaving them unattached and destabilizing the cell wall.

• Result: The cell wall becomes unstable and the bacterium bursts from osmotic pressure.

• Example: Penicillin inhibits peptidoglycan cross-linking.

Disruption of Cytoplasmic Membrane Integrity

Some drugs target the cytoplasmic membrane, forming channels that compromise membrane integrity and lead to cell death.

• Key Difference: Fungal membranes contain ergosterol, while human membranes contain cholesterol.

• Mechanism: Drugs like Amphotericin B bind to ergosterol, forming pores in fungal membranes.

• Clinical Use: Amphotericin B is used to treat systemic fungal infections such as thrush.

• Selective Toxicity: Human cells are less affected due to the presence of cholesterol instead of ergosterol.

Inhibition of Protein Synthesis

Antibiotics can target bacterial ribosomes, which differ structurally from eukaryotic ribosomes, allowing selective inhibition of protein synthesis.

• Ribosome Structure: Bacterial ribosomes are 70S (composed of 30S and 50S subunits).

• Mechanisms:

  • Aminoglycosides: Change the shape of the 30S subunit, causing misreading of mRNA.

  • Tetracyclines: Block docking of tRNA to the ribosome.

  • Chloramphenicol: Blocks peptide bond formation at the 50S subunit.

• Result: Inhibition of protein synthesis leads to cell death or stasis.

Inhibition of Nucleic Acid Synthesis

Some drugs interfere with the synthesis of DNA or RNA, affecting replication and transcription.

• Nucleotide/Nucleoside Analogs: Mimic natural nucleotides, causing faulty DNA/RNA synthesis.

• Polymerase Inhibition: Viral polymerases are more likely to incorporate these analogs, making them useful for treating viral infections.

• Example: Thymidine analogs are used in antiviral therapy.

Inhibition of Metabolic Pathways

Some drugs target unique metabolic pathways in microbes, such as folic acid synthesis in bacteria.

• Folic Acid Synthesis: Bacteria synthesize folic acid; humans obtain it from their diet.

• Mechanism: Sulfonamides are structural analogs of para-aminobenzoic acid (PABA) and competitively inhibit the enzyme involved in folic acid synthesis.

• Example: Sulfanilamide, Sulfamethoxazole, Sulfisoxazole.

Properties of Ideal Antimicrobial Drugs

Characteristics

An ideal antimicrobial drug should possess several key properties to maximize efficacy and minimize harm.

• Readily available

• Inexpensive

• Chemically stable

• Easy to administer

• Nontoxic and nonallergenic

• Selectively toxic against a wide range of pathogens

Note: No drug is perfect; clinicians must weigh benefits and risks.

Spectrum of Action

Narrow vs. Broad Spectrum

The spectrum of action refers to the range of pathogens a drug can target.

• Narrow-spectrum: Effective against a limited group of pathogens (e.g., Gram-positive bacteria).

• Broad-spectrum: Effective against a wide variety of pathogens (e.g., both Gram-positive and Gram-negative bacteria).

• Risks: Broad-spectrum drugs may disrupt normal microbiota, leading to secondary or superinfections.

Testing the Efficacy of Antimicrobial Drugs

Methods

Several laboratory methods are used to determine the effectiveness of antimicrobial agents against specific microbes.

• Disk Diffusion (Kirby-Bauer) Test: Measures the zone of inhibition around antibiotic disks placed on an agar plate inoculated with bacteria.

• Minimum Inhibitory Concentration (MIC) Test: Determines the lowest concentration of an antibiotic that inhibits visible growth of a microorganism.

• Etest: Uses a plastic strip with a gradient of antibiotic concentration to determine MIC directly on an agar plate.

Test	Main Purpose	Result Interpretation
Disk Diffusion	Compare susceptibility	Zone of inhibition size
MIC Test	Find minimum effective dose	Lowest concentration with no growth
Etest	Quantitative MIC on agar	Elliptical zone intersects strip at MIC

Development of Antimicrobial Resistance

Mechanisms of Resistance

Microbes can develop resistance to antibiotics through various mechanisms, making treatment more challenging.

• Enzymatic Destruction: Production of enzymes (e.g., beta-lactamases) that inactivate antibiotics.

• Prevention of Entry: Alteration of membrane proteins to block drug entry.

• Alteration of Target: Modification of drug target sites (e.g., ribosomal proteins).

• Efflux Pumps: Proteins that actively transport drugs out of the cell.

• Metabolic Pathway Changes: Bypass or upregulation of metabolic pathways targeted by drugs.

• Biofilm Formation: Slows drug diffusion and protects bacteria.

• Target Protection: Proteins (e.g., MfpA in Mycobacterium tuberculosis) mimic DNA and protect targets from antibiotics.

Genetic Basis of Resistance

• Mutation: Spontaneous changes in chromosomal genes.

• Horizontal Gene Transfer: Acquisition of resistance genes via transformation, transduction, or conjugation (e.g., R-plasmids).

Cross Resistance

Occurs when a pathogen becomes resistant to multiple drugs, often due to shared mechanisms or genetic elements.

Limiting Resistance

Strategies

• Use antibiotics only when necessary.

• Complete the full course of prescribed antibiotics.

• Use combination therapy to reduce the likelihood of resistance.

• Monitor and control antibiotic use in healthcare settings.

Summary Messages

• Antimicrobial drug resistance is as old as antimicrobial drugs themselves.

• Multiple mechanisms exist for microbes to develop resistance.

• Proper use of antibiotics and combination therapy are key strategies to limit resistance.

Additional info: Some context and explanations were inferred from fragmented notes and standard microbiology knowledge to ensure completeness and clarity.